A newly studied blood test could be the answer to a serious question: How can a woman tell if she has ovarian cancer in its earliest stage?
Currently, there are no approved screening techniques from the Food and Drug Administration … Read more
By: The Clearity Foundation
#GivingTuesday is a global day of giving fueled by the power of social media and collaboration.
Celebrated on the Tuesday following Thanksgiving (in the U.S.) and the widely recognized shopping events Black Friday and Cyber Monday, … Read more
One in five patients with ovarian cancer said that they would not be willing to travel an additional 50 miles for cancer care for only a 6% 5-year survival benefit, according to the results of a study published in Gynecologic … Read more
Anne Hermiller and Sarah Ludinich experienced ovarian cancer at different stages in life. What’s similar is their passion for making other women more aware of the disease and its effects.
Hermiller, of Findlay, learned she had cancer in 2014. “I … Read more
An article published in the Gynecologic Oncology Research and Practice reviews the current medications available for treatment of ovarian cancer.
Epithelial ovarian cancer is commonly diagnosed in its advanced stages. Although current management for ovarian cancer is effective in inducing … Read more
Investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute are leveraging the power of artificial intelligence to develop a new technique to detect ovarian cancer early and accurately. The team has identified a network of circulating microRNAs – small, … Read more
When it comes to cancer types that disproportionately affect women, breast cancer gets a lot of buzz. And by all means, continue your regular self-exams and mammograms, please! Still, it’s important to tune in to the signs of ovarian cancer, … Read more
Platinum/taxane combinations are the most effective regimens for treatment of epithelial ovarian cancer. Response varies between patients, but because the molecular basis for resistance is not defined, patients receive so-called one size fits all therapy. In contrast, elucidation of the … Read more
Many of the most severe ovarian cancer cases may originate in the fallopian tube (FT), based on data from an analysis of nine patients published online in Nature Communications.
“Our data suggest that FT neoplasia is the origin of ovarian … Read more
Anne Cope was never alone.
As the 66-year-old endured chemotherapy while she battled ovarian cancer, she could count on one thing: her children would be there by her side.
Her husband, Nick Milonas, has serious health issues, which prevented him … Read more
Join OCRFA on Monday, Oct. 23rd at 6:00pm ET for a webinar on PARP Inhibitors with Dr. Ursula Matulonis of Dana-Farber Cancer Institute.
There is a great amount of excitement in the ovarian cancer clinical and research communities about the … Read more
Most – and possibly all – ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.
This is the finding of a multicenter study of ovarian cancer genetics led by researchers from Perlmutter Cancer Center … Read more
Don’t delay platinum-based chemotherapy in favor of single-agent non-platinum-based chemotherapy in patients with partially platinum-sensitive ovarian cancer, Italian researchers advised.
Introducing non-platinum chemotherapy to prolong the platinum-free interval (PFI) in patients with progressing ovarian cancer who experience disease recurrence, or … Read more
More than 22,000 American women are diagnosed with ovarian cancer each year. As Ovarian Cancer Awareness Month comes to a close, we believe in recognizing ovarian cancer organizations and advocates fighting to make a difference.
We’ve highlighted ovarian cancer organizations … Read more
To better understand ovarian cancer, as well as predict when women might relapse, it is crucial that researchers start investigating more of the molecular phases of the disease, says Peter Dottino, M.D.
Studies are already underway in this area, and … Read more
More research is needed on the other genetic mutations, besides BRCA, that patients with ovarian cancer harbor so that they can be used to help plan treatments.
However, there is hope for such research to emerge. Ophira Ginsburg, M.D., director … Read more
One of the biggest challenges for cancer survivors can be simply not thinking about their cancer once they’ve tamed the beast and been declared cancer-free. As an ovarian cancer patient, I’d venture to speculate that it’s even harder for those … Read more
By: Amy King
My mom was diagnosed with ovarian cancer on my parents’ 36th wedding anniversary. They called me together, while I was at work, to tell me the news. Our lives suddenly became very different lives.
My parents live … Read more
In 2016, the American Cancer Society projected that the number of women dying worldwide from cancer was expected to rise to 5.5 million by 2030.1 In the realm of women’s cancers, ovarian cancer is prominent and serious. A woman … Read more
